» Articles » PMID: 22472772

The Impact of Alcohol and Illicit Drugs on People with Psychosis: the Second Australian National Survey of Psychosis

Overview
Specialty Psychiatry
Date 2012 Apr 5
PMID 22472772
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To provide the most up-to-date prevalence estimates of alcohol and illicit drug use among individuals with psychosis in Australia, and explore correlates associated with a lifetime diagnosis of both alcohol abuse/dependence and cannabis abuse/dependence.

Method: This paper uses data from the Survey of High Impact Psychosis (SHIP), conducted as a follow-up to the first Australian National Low Prevalence (Psychotic) Disorders Study (1997-1998). The SHIP was a national study, carried out across five states, in which a sample of 1825 individuals was recruited through a two-phase sampling framework.

Results: Alcohol and illicit drug use was highly prevalent for the entire sample. There were few significant differences in the prevalence or frequency of use across the diagnostic categories examined. Substantial increases in substance abuse/dependence were noted since the 1997-1998 survey (51% diagnosed with alcohol abuse/dependence, 51% with cannabis abuse/dependence and 32% with other illicit drug abuse/dependence, compared to 28%, 23% and 12% respectively, in the 1997-1998 survey by Kavanagh et al., 2004). Factors significantly associated with both lifetime alcohol and cannabis dependence included male gender, younger age, single marital status, lower educational attainment, shorter duration of illness, lifetime presence of hallucinations, higher negative syndrome score and lower body mass index (BMI). A number of other factors were found to be differentially associated with either lifetime alcohol or cannabis dependence.

Conclusions: The use of alcohol and illicit substances is common among people with a psychotic illness, with a concerning upward trend in rates of substance abuse/dependence since the 1997-1998 survey. Clinicians should be aware of the potential impact of concurrent substance use and provide integrated treatment for individuals presenting with psychotic illnesses. More research and investment in new intervention programs is required.

Citing Articles

Risks for re-hospitalization of persons with severe mental illness living in rehabilitation care settings.

Nisim U, Zlotnick C, Roe D, Gelkopf M, Shadmi E Isr J Health Policy Res. 2024; 13(1):18.

PMID: 38570853 PMC: 10993576. DOI: 10.1186/s13584-024-00605-z.


Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data.

Patel R, Chan K, Palmer E, Valko M, Guruswamy G, Ker S Schizophr Res. 2023; 260:191-197.

PMID: 37683509 PMC: 10881404. DOI: 10.1016/j.schres.2023.08.023.


Evaluating schizotypy and alcohol usage as predictors of increased engagement in risky sexual behaviors in an undergraduate sample.

Cartier M, Dinzeo T Curr Psychol. 2022; :1-9.

PMID: 35910237 PMC: 9326141. DOI: 10.1007/s12144-022-03476-2.


Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review.

Coles A, Knezevic D, George T, Correll C, Kane J, Castle D Front Psychiatry. 2022; 12:808002.

PMID: 34975600 PMC: 8715086. DOI: 10.3389/fpsyt.2021.808002.


Problematic Drug Use Among Outpatients With Schizophrenia and Related Psychoses.

Chang S, Jeyagurunathan A, Lau J, Shafie S, Samari E, Cetty L Front Psychiatry. 2021; 12:762988.

PMID: 34744843 PMC: 8569375. DOI: 10.3389/fpsyt.2021.762988.